tobacco – Page 5 – Oral Cancer News

Penn surgeons become world’s first to test glowing dye for cancerous lymph nodes

Source: www.phillyvoice.com Author: Michael Tanenbaum, PhillyVoice Staff Surgeons at the University of Pennsylvania have achieved a global first with the use of a fluorescent dye that identifies cancerous cells in lymph nodes during head and neck cancer procedures. The study, led by otorhinolaryngologist Jason G. Newman, seeks to test the effectiveness of intraoperative molecular imaging (IMI), a technique that illuminates tumors to provide real-time surgical guidance. More than 65,000 Americans will be diagnosed with head and neck cancers in 2017, accounting for approximately 4 percent of all cancers in the United States, according to the National Cancer Institute. About 75 percent of these cancers are caused by tobacco and alcohol use, followed by human papillomavirus (HPV) as a growing source for their development. Common areas affected by these cancers include the mouth, throat, voice box, sinuses and salivary glands, with typical treatments including a combination of surgery, radiation and chemotherapy. Lymph nodes, which act as filters for the immune system, are often among the first organs affected by head and neck cancers as they spread or resurface. Initial surgeries may leave microscopic cancerous cells undetected in the lymphoid tissue, heightening the risk that a patient's condition will return after the procedure. “By using a dye that makes cancerous cells glow, we get real-time information about which lymph nodes are potentially dangerous and which ones we can leave alone,” Newman said. “That not only helps us remove more cancer from our patients during surgery, it also improves our ability to spare [...]

Oral Cancer Foundation News Team - A2017-10-11T12:33:52-07:00October, 2017|Oral Cancer News|

Alcohol industry ‘playing down’ risk of cancer by using tobacco industry tactics

Source: news.sky.com Author: Paul Kelso, Health Correspondent The alcohol industry is misleading the public by downplaying the risk of cancer through similar tactics to the tobacco industry, researchers say. Liquor bottles in grocery store A study led by the London School of Hygiene and Tropical Medicine (LSHTM) and Sweden's Karolinska Institutet found the industry is using "denying, distortion and distraction" strategies to minimise evidence. Researchers analysed information relating to cancer on the websites and documents of 28 alcohol industry organisations between September and December last year, finding that most showed "some sort of distortion or misrepresentation" of evidence. The industry most commonly presented the relationship between alcohol and cancer as highly complex, implying there was no evidence of a consistent or independent link, according to the study. Other tactics included denying that any relationship existed or claiming that there was no risk for light or moderate drinking, as well as presenting alcohol as just one risk among many. Alcohol consumption is an established risk factor for a range of cancers, including oral cavity, liver, breast and colorectal cancers, and accounts for about 4% of new cancer cases annually in the UK. The latest British government advice on alcohol, issued last year, makes an explicit link between cancer and alcohol. It states: "The risk of developing a range of health problems (including cancers of the mouth, throat and breast) increases the more you drink on a regular basis." During the consultation phase the alcohol industry challenged the link with cancer. [...]

Oral Cancer Foundation News Team - A2017-09-08T11:53:23-07:00September, 2017|Oral Cancer News|

Smoking Scenes in Movies Have Increased … Why?

Source: www.healthline.com Author: Shawn Radcliffe After several years of decline, tobacco use depicted in movies is on the rise again. Does it matter? Where there’s smoke, there’s … probably a PG-13 rated movie. A new study shows that tobacco incidents depicted in top-grossing movies in the United States are once again on the rise, breaking an earlier decline. This is true despite public health efforts outside theaters to reduce smoking by children and teens. “If the progress that we had seen between 2005 and 2010 had continued, all of the youth-rated films would have been smoke-free in 2015,” said study author Stanton Glantz, PhD, professor of medicine, and director of the University of California San Francisco (UCSF) Center for Tobacco Control Research and Education. The July 7 study in the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report (MMWR) found that the total number of tobacco incidents in top-grossing movies increased 72 percent between 2010 and 2016. It also increased 43 percent in PG-13 movies. Tobacco incidents are defined as use or implied use, by an actor, of cigarettes, cigars, pipes, hookah, smokeless tobacco products, or electronic cigarettes. This increase comes as the number of movies showing tobacco declined — meaning fewer movies account for a greater number of tobacco scenes. In 2016, 41 percent of the top-grossing movies had tobacco incidents, down from 45 percent in 2010. In addition, 26 percent of youth-rated movies had tobacco incidents in 2016, a decline from 31 percent in 2010. [...]

Oral Cancer Foundation News Team - A2017-07-15T18:00:58-07:00July, 2017|Oral Cancer News|

House Committee Looks to Dilute Tobacco Control Act

Source: www.medpagetoday.com Date: July 12, 2017 Author: Salynn Boyles The U.S. House Appropriations Committee made a move Wednesday to greatly weaken the FDA's authority to regulate tobacco products, including flavored cigars and electronic cigarettes, and health advocacy groups were quick to condemn it. The committee approved a rider to the agriculture funding bill that would exempt certain cigars from FDA's authority and weaken its regulatory oversight over e-cigarettes, little cigars, and hookah tobacco. Prior to the vote, the House committee defeated an amendment by Rep. Nita Lowey (D-N.Y.) to remove language from the bill that will effectively eliminate FDA's authority to review the health hazards of thousands of tobacco products. A second rider would exempt from FDA authority certain cigars, including many that are cheap, flavored and are most likely to appeal to children, said American Lung Association (ALA) President Harold Wimmer. "These dangerous riders were added to this bill for the benefit of the tobacco industry and come at a time when e-cigarettes are the most commonly used tobacco product among kids," Wimmer said in a written press statement. The riders are similar to those passed by the House Appropriations Committee last year, but the language restricting FDA's authority under the Tobacco Control Act was dropped from the final FY2017 bill later in the appropriations process. New language in the FY2018 bill does require the FDA to develop standards for the flavors added to e-cigarettes. ALA spokesperson Erika Sward told MedPage Today that it is not clear if the [...]

Charlotte Parker2017-07-13T11:02:13-07:00July, 2017|Oral Cancer News|

Novel vaccine therapy can generate immune responses in patients with HPV-related head and neck cancer

Source: www.news-medical.net Author: staff A novel vaccine therapy can generate immune responses in patients with head and neck squamous cell carcinoma (HNSCCa), according to researchers at the Abramson Cancer Center of the University of Pennsylvania. The treatment specifically targets human papillomavirus (HPV), which is frequently associated with HNSCCa, to trigger the immune response. Researchers will present the results of their pilot study during the 2017 American Society of Clinical Oncology Annual Meeting in Chicago (Abstract #6073). HNSCCa is a cancer that develops in the mucous membranes of the mouth, and throat. While smoking and tobacco use are known causes, the number of cases related to HPV infection - a sexually transmitted infection that is so common, the Centers for Disease Control says almost all sexually active adults will contract it at some point in their lifetimes - is on the rise. The CDC now estimates 70 percent of all throat cancers in the United States are HPV-related. Sixty percent are caused by the subtype known as HPV 16/18. "This is the subtype we target with this new therapy, and we're the only site in the country to demonstrate immune activation with this DNA based immunotherapeutic vaccine for HPV 16/18 associated head and neck cancer," said the study's lead author Charu Aggarwal, MD, MPH, an assistant professor of Hematology Oncology in the Perelman School of Medicine at the University of Pennsylvania. The vaccine is delivered as an injection of antigens - which leads the immune system to start producing antibodies and [...]

Oral Cancer Foundation News Team - A2017-06-01T13:08:47-07:00June, 2017|Oral Cancer News|

European Commission approves Bristol-Myers Squibb’s Opdivo (nivolumab) for squamous cell cancer of the head and neck in adults progressing on or after platinum-based therapy

Source: pipelinereview.com Author: Bristol-Myers Squibb Bristol-Myers Squibb Company today announced that the European Commission (EC) has approved Opdivo (nivolumab) as monotherapy for the treatment of squamous cell cancer of the head and neck (SCCHN) in adults progressing on or after platinum-based therapy. Opdivo is the first and only Immuno-Oncology (I-O) treatment that demonstrated in a Phase 3 trial a significant improvement in overall survival (OS) for these patients. “Adult patients with squamous cell cancer of the head and neck that progresses on or after platinum-based therapy are fighting a debilitating and hard-to-treat disease that is associated with a very poor prognosis,” said Kevin Harrington, M.D., Ph.D., professor in Biological Cancer Therapies at The Institute of Cancer Research, London, and a consultant clinical oncologist at The Royal Marsden NHS Foundation Trust in London. “As an oncologist who helps patients deal with this terrible disease, I hope that nivolumab will now be made available as widely as possible, offering this group of patients a new treatment option that can potentially improve their overall survival." The approval was based on results from CheckMate -141, a global Phase 3, open-label, randomized trial, first published in The New England Journal of Medicine last October, which evaluated Opdivo versus investigator’s choice of therapy in patients aged 18 years and above with recurrent or metastatic, platinum-refractory SCCHN who had tumor progression during or within six months of receiving platinum-based therapy administered in the adjuvant, neo-adjuvant, primary or metastatic setting. Investigator’s choice of therapy included methotrexate, docetaxel, or [...]

Oral Cancer Foundation News Team - A2017-04-30T12:46:16-07:00April, 2017|Oral Cancer News|

Epigenetic modification discovered in adult throat cancers

Source: www.specialtypharmacytimes.com Author: Lauren Santye, Assistant Editor An epigenetic modification may be the cause of 15% of adult head and neck cancers that are linked to tobacco and alcohol use, according to a study published in Nature Genetics. Although the body is made up of a large number of different types of cells––neurons, skins cells, fat cells, immune cells–– they all have the same DNA or genome. It was not until recently that scientists discovered their differences can be explained by epigenetics. “This discovery was absolutely unexpected since it seemed highly improbable that the kind of alterations of the epigenome that we had previously found in other types of tumors in children and young adults could also target an epithelial tumor like throat cancer that occurs only in adults,” said Dr Nada Jabado. There are already some promising drug molecules currently on the market for other diseases that could be tested for head and neck cancers, as well as other cancer types, according to the study. Additionally, the investigators hope that the findings could help in developing treatments for pediatric patients. “Now that we’ve identified this cohort of patients, we can move quite quickly since the case of adults, as opposed to children, there are more patients and lots of clinical trials,” Dr Jabado said. “The medicines could then be tested on children afterward.” Dr Jabado’s work focuses on epigenetics in pediatric cancers, particularly on the mutations of the histone H3 protein. In particular, the investigators were interested in a [...]

Oral Cancer Foundation News Team - A2017-01-20T08:56:52-07:00January, 2017|Oral Cancer News|

Genetic variants are associated with susceptibility to mouth and throat cancer

Source: www.eurekalert.org Author: news release A number of genetic variants associated with susceptibility to oral cavity and pharyngeal cancer have been described in an international study published in the journal Nature Genetics. The most noteworthy finding was an association between cancer of the oropharynx and certain polymorphisms (alternative versions of a given DNA sequence) found in the human leukocyte antigen (HLA) genomic region. HLAs, proteins found on the surface of most cells in the body, play an important role in recognizing potential threats and triggering the immune response to foreign substances. According to Eloiza Helena Tajara, a professor at the São José do Rio Preto Medical School (FAMERP) in São Paulo State, Brazil, and co-author of the article, a specific group of variants in this region, located on chromosome 6, is associated with enhanced protection against oropharyngeal cancer caused by human papilloma virus (HPV). "Previous research showed that these same variants confer protection against cancer of the uterine cervix, which is known to be associated with HPV," Tajara said. "Our findings suggest that the genes that control the immune system play a key role in predisposition to HPV-related tumors. This discovery points to the possibility of clarifying the mechanisms whereby such tumors develop and of designing methods for monitoring risk groups." The study was coordinated by the International Agency for Research on Cancer (IARC) and involved 40 research groups in Europe, the United States, and South America. The Brazilian participants are members of the Head & Neck Genome Project (GENCAPO), [...]

Oral Cancer Foundation News Team - A2016-12-17T11:02:17-07:00December, 2016|Oral Cancer News|

For this cancer, ‘stage 4’ isn’t as bad as it sounds

Source: www.omaha.com Author: Steve Hendrix - The Washington Post Hearing the word "cancer" in a doctor's office is bad enough. Hearing "stage 4" invokes even more dread. When I learned I had stage 4 HPV-related oral cancer, I didn't know exactly what it meant, but I knew there wasn't a stage 5. Doctors use the standardized staging system to describe the location, size and extent of a cancer and its spread throughout the body. Using data on the treatment and survivability of each particular kind of cancer, clinicians combine these factors to produce a number from stage 1 (a small tumor confined to one spot) to stage 4 (a cancer that has spread, either to a single adjacent lymph node or to distant organs). My cancer was stage 4A, a small tumor at the base of my tongue that had spread to a single lymph node in my neck. My doctor immediately tried to soften the blow. There were problems with the staging rules as they applied to this kind of cancer, he said. HPV oropharyngeal cancers, while potentially fatal, were far more treatable than other oral cancers, particularly the ones related to tobacco and alcohol use that were used to define the staging standards. He was right. A study published in the Lancet early this year found that the current guidelines lead to needless panic for the newly diagnosed. "At the present time, most patients with HPV+ oropharyngeal cancer are told they have (stage 4) disease, but the reality [...]

Oral Cancer Foundation News Team - A2016-11-21T10:00:30-07:00November, 2016|Oral Cancer News|

Tobacco is OUT! A third of all Major League Baseball stadiums to be free of tobacco

Source: www.dailyastorian.com Author: American Heart Association News With the end of this baseball season, so ended the long intertwined history of tobacco and baseball at more than one-third of all Major League stadiums. The unhealthy coupling started unraveling when it became evident that chewing tobacco resulted in deadly consequences for some players, such as legendary San Diego Padre Tony Gwynn who died of mouth cancer in 2014. Just months after Gwynn’s death, former Boston Red Sox pitcher Curt Schilling announced he was being treated for oral cancer. Although Major League Baseball and the players’ union could not agree to take action, several cities have. Boston, Chicago, Los Angeles, New York and San Francisco all have passed laws prohibiting tobacco use of any kind at sports venues. A statewide law in California will take effect before the 2017 season begins. This week, the Washington, D.C. City Council gave final approval to a measure that would end the use of all tobacco products – including smokeless tobacco like chew, dip and snuff – at all organized sporting events within the city, including Nationals Park. Councilmember Yvette Alexander said the move is needed to help protect children, who often look to sports professionals as role models, from taking up the habit. The measure will now be sent to Mayor Muriel Bowser to sign into law. Additionally, on Oct. 20, St. Petersburg, Florida, City Council Vice Chair Darden Rice introduced a proposal to ban smokeless tobacco products from the city’s athletic venues. The proposal [...]

Oral Cancer Foundation News Team - A2016-11-06T12:23:57-07:00November, 2016|Oral Cancer News|